Dennis C Sgroi Selected Research

Dennis C Sgroi Research Topics

Disease

46	Neoplasms (Cancer) 10/2021 - 07/2002
44	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2002
5	Carcinogenesis 01/2021 - 12/2005
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2006
3	Ductal Carcinoma 01/2019 - 05/2004
3	Endometrial Neoplasms (Endometrial Cancer) 11/2014 - 03/2011
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2014 - 11/2002
2	Triple Negative Breast Neoplasms 06/2012 - 03/2010
2	Lung Neoplasms (Lung Cancer) 11/2011 - 07/2006
2	Adenocarcinoma 07/2006 - 11/2005
2	Hyperglycemia 03/2002 - 02/2002
1	Lobular Carcinoma 10/2021
1	Rhabdomyosarcoma 01/2019
1	Brain Neoplasms (Brain Tumor) 03/2014
1	Chromosomal Instability (Chromosome Stability) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 11/2011
1	Colonic Neoplasms (Colon Cancer) 11/2011
1	Glioma (Gliomas) 11/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2011
1	Hypersensitivity (Allergy) 08/2011
1	Aneuploidy (Aneuploid) 08/2011
1	Genomic Instability 08/2011
1	Type 2 Diabetes Mellitus (MODY) 07/2010
1	Dehydration (Water Stress) 01/2009
1	Hypoxia (Hypoxemia) 03/2008
1	Ovarian Neoplasms (Ovarian Cancer) 10/2007
1	Disease Progression 10/2007
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2006
1	Stomach Neoplasms (Stomach Cancer) 02/2006
1	Oncogene Addiction 02/2006
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2005

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2007
17	Tamoxifen FDA LinkGeneric 01/2022 - 06/2004
15	Estrogen ReceptorsIBA 01/2017 - 06/2004
14	Proteins (Proteins, Gene)FDA Link 09/2017 - 11/2002
9	Hormones (Hormone)IBA 01/2022 - 06/2004
7	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2022 - 03/2013
7	Biological ProductsIBA 03/2014 - 11/2005
6	Phosphotransferases (Kinase)IBA 01/2018 - 05/2005
6	Progesterone Receptors (Progesterone Receptor)IBA 05/2014 - 10/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2003
4	ErbB Receptors (EGF Receptor)IBA 03/2014 - 11/2005
3	Estrogens (Estrogen)FDA Link 01/2018 - 11/2007
3	Transcription Factors (Transcription Factor)IBA 01/2011 - 12/2005
3	Gefitinib (Iressa)FDA Link 07/2006 - 11/2005
3	Tyrosine Kinase InhibitorsIBA 07/2006 - 11/2005
3	Messenger RNA (mRNA)IBA 12/2005 - 02/2002
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 01/2014
2	LigandsIBA 01/2021 - 08/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 03/2014
2	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 03/2014
2	Formaldehyde (Formol)FDA Link 01/2016 - 10/2006
2	ParaffinIBA 01/2016 - 10/2006
2	Tyrosine (L-Tyrosine)FDA Link 11/2014 - 01/2006
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2014 - 07/2006
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2014 - 06/2012
2	Interleukin-17 (Interleukin 17)IBA 09/2008 - 04/2006
2	Growth Factor ReceptorsIBA 04/2006 - 02/2006
2	Pharmaceutical PreparationsIBA 02/2006 - 01/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2002 - 03/2002
2	PhlorhizinIBA 03/2002 - 02/2002
1	CarcinogensIBA 01/2021
1	anthraceneIBA 01/2021
1	CC ChemokinesIBA 01/2021
1	olaparibIBA 01/2019
1	PhosphoproteinsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2016
1	GTP-Binding Proteins (G-Protein)IBA 05/2014
1	NucleotidesIBA 01/2014
1	Anastrozole (Arimidex)FDA LinkGeneric 10/2013
1	Ligases (Synthetase)IBA 12/2012
1	UbiquitinIBA 12/2012
1	p38 Mitogen-Activated Protein KinasesIBA 06/2012
1	Tumor Biomarkers (Tumor Markers)IBA 11/2011
1	Nonsense Codon (Nonsense Mutation)IBA 08/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2011
1	Fulvestrant (Faslodex)FDA Link 01/2011
1	ProteomeIBA 11/2010
1	Cisplatin (Platino)FDA LinkGeneric 03/2010
1	A-Form DNA (A-DNA)IBA 03/2010
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2009
1	Metalloproteases (Metalloproteinases)IBA 01/2009
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2008
1	Cysteine (L-Cysteine)FDA Link 08/2008
1	Peptides (Polypeptides)IBA 08/2008
1	ChemokinesIBA 03/2008
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2006
1	Capecitabine (Xeloda)FDA Link 07/2006
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 02/2006
1	Protein Isoforms (Isoforms)IBA 01/2006
1	Proto-Oncogene Proteins c-etsIBA 12/2005

Therapy/Procedure

15	Therapeutics 01/2022 - 05/2005
13	Lasers (Laser) 03/2014 - 07/2002
2	Adjuvant Chemotherapy 03/2013 - 05/2008
2	Molecular Targeted Therapy 02/2006 - 05/2005
1	Cell Transplantation 01/2019
1	Drug Therapy (Chemotherapy) 12/2017
1	Complementary Therapies (Alternative Medicine) 04/2006